Sivik Global Healthcare’s DexCom DXCM Stock Holding History

Sivik Global Healthcare’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-30,000	Closed	-$3.4M	–	39
2024 Q2	$3.4M	Sell	30,000 -5,000	-14%	-$632K	1.22%	30
2024 Q1	$4.86M	Sell	35,000 -15,000	-30%	-$1.89M	1.14%	31
2023 Q4	$6.21M	Hold	50,000	–	–	2.59%	17
2023 Q3	$4.67M	Buy	+50,000	New	+$5.64M	2.36%	25
2019 Q2	–	Sell	-50,000	Closed	-$1.49M	–	63
2019 Q1	$1.49M	Buy	50,000 +20,000	+67%	+$703K	0.55%	56
2018 Q4	$899K	Sell	30,000 -50,000	-63%	-$1.59M	0.48%	43
2018 Q3	$2.86M	Buy	80,000 +36,400	+83%	+$1.13M	1.02%	42
2018 Q2	$1.03M	Buy	+43,600	New	+$924K	0.4%	59

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sivik Global Healthcare's DXCM Position: Q3 2024 in Review

Sivik Global Healthcare sold out of DexCom (DXCM) in Q3 2024, closing a stake of 30,000 shares — an estimated $3.4M sold.

Sivik Global Healthcare first reported a position in DXCM in Q2 2018 and held it in 8 quarters. The position peaked at $6.21M in Q4 2023. 890 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

Sivik Global Healthcare reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
Sivik Global Healthcare sold 30,000 DexCom shares in Q3 2024, an estimated $3.4M.
Sivik Global Healthcare first reported a position in DexCom in Q2 2018 and held it in 8 quarters.
Sivik Global Healthcare's DexCom position peaked at $6.21M in Q4 2023.
890 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Sivik Global Healthcare's 13F filing for Q3 2024, filed 6 Nov 2024.